BRAVECARE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 18.4% 6.8% 3.1% 10.9%  
Credit score (0-100)  0 7 34 56 21  
Credit rating  N/A B BBB BBB BB  
Credit limit (kEUR)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kEUR) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -28.2 -123 379 -882  
EBITDA  0.0 -57.3 -151 -6.3 -962  
EBIT  0.0 -57.3 -151 -18.2 -976  
Pre-tax profit (PTP)  0.0 -57.3 -147.5 0.4 -907.3  
Net earnings  0.0 -57.3 -147.5 0.4 -907.3  
Pre-tax profit without non-rec. items  0.0 -57.3 -148 0.4 -907  

 
See the entire income statement

Balance sheet (kEUR) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 36.9 37.2 23.9  
Shareholders equity total  0.0 -7.3 1,227 1,222 259  
Interest-bearing liabilities  0.0 0.0 927 1,879 1,251  
Balance sheet total (assets)  0.0 29.3 2,405 3,682 1,983  

Net Debt  0.0 -29.3 123 1,501 228  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -28.2 -123 379 -882  
Gross profit growth  0.0% 0.0% -337.2% 0.0% 0.0%  
Employees  0 1 1 3 2  
Employee growth %  0.0% 0.0% 0.0% 200.0% -33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 29 2,405 3,682 1,983  
Balance sheet change%  0.0% 0.0% 8,100.7% 53.1% -46.1%  
Added value  0.0 -57.3 -150.6 -18.2 -962.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 684 -278 20  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 203.7% 122.4% -4.8% 110.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -156.4% -12.0% 0.0% -32.0%  
ROI %  0.0% 0.0% -13.6% 0.0% -39.3%  
ROE %  0.0% -195.5% -23.5% 0.0% -122.5%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% -20.0% 51.0% 33.2% 13.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 51.2% -81.8% -23,649.3% -23.7%  
Gearing %  0.0% 0.0% 75.6% 153.8% 482.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.2% 0.1% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.8 1.5 1.3 1.2  
Current Ratio  0.0 0.8 1.5 1.3 1.2  
Cash and cash equivalent  0.0 29.3 803.9 378.4 1,022.9  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 96.9 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -7.3 542.5 804.2 208.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -57 -151 -6 -481  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -57 -151 -2 -481  
EBIT / employee  0 -57 -151 -6 -488  
Net earnings / employee  0 -57 -148 0 -454